PHILIP WOLFSON

Philip Wolfson
President & CEO of Ketamine Research Foundation

Ketamine Assisted Psychotherapy (KAP)—Trance and Transformation - The First Legal Psychedelic Psychotherapy

Ketamine as an assisted psychotherapy is the first legally available psychedelic medicine in the toolbox. We have been developing KAP and training KAP practitioners—by year’s end 260 worldwide-- didactically and experientially in our methodology. Workshop participants will be presented with KAP’s potentialities, our methods of practice, the generation of psychedelic psychotherapy in the KAP process, and its utility and benefits for a variety of diagnoses and human dilemmas. We invite those qualified to train and administer KAP as a breakthrough modality. Our non-profit Ketamine Research Foundation contains the full human studies bibliography; our research projects, data collection process, and much more. Our just published first ever KAP study of 235 patients is available at the JoPD.

Phil Wolfson MD is the co-creator of a new psychotherapy modality based on use of the legal psychedelic medicine ketamine—Ketamine Assisted Psychotherapy (KAP). Phil is the President & CEO of the non-profit Ketamine Research Foundation and directs the training of KAP practitioners through The Ketamine Training Centre. He is the author of The Ketamine Papers and Noe – A Father/Son Song of Love, Life, Illness and Death. He has been the Principal Investigator of the recently completed MAPS.org study of MDMA treatment for individuals with life-threatening illnesses. Dr. Wolfson’s work is the result of an intense, now many decades long clinical psychiatry/psychotherapy/psychedelic medicine practice.